Abstract
Abstract
Background
The subcutaneous injection of lokivetmab at day zero at the labeled dose range of 2mg/kg was evaluated in 106 dogs recruited from two private clinics in the State of São Paulo, Brazil. The objective of this 30-day open-label, non-controlled study was to evaluate the level of improvement in cases of canine Atopic Dermatitis (cAD) using the Canine atopic dermatitis extent and severity index (CADESI-4), Visual analogue scale (VAS) of pruritus, the incidence of adverse events, and owner’s perception of the treatment response by Global assessment of efficacy (OGATE).
Results
Baseline mean VAS of pruritus was 7.75 (median = 7), decreasing to 3.86 (median = 2) at day 2 ( p < 0.001). CADESI-4 scores decreased from 36.65 at baseline to 16.47 at day 30 (p < 0.001). Reports of treatment responses submitted by owners and evaluation of CADESI-4 after treatment were significantly similar (p < 0.001). Owners rated the response to treatment as good to excellent for 73,5% of the dogs. Adverse events, including vomiting, diarrhea, and/or lethargy, were observed in 18 dogs (17%). All events were transient, and none required treatment.
Conclusions
Based on findings in this study, lokivetmab was determined to provide a rapid and effective response for control of cAD. Lokivetmab was well tolerated with only mild and transient adverse events observed.
Publisher
Research Square Platform LLC
Reference23 articles.
1. Canine atopic dermatitis: detailed guidelines for diagnosis and allergen identification;Hensel P;BMC Vet Res,2015
2. Review: innate immunity, lipid metabolism and nutrition in canine atopic dermatitis;Pucheu-Haston CM;Vet Dermatol,2015
3. Review: Clinical and histological manifestations of canine atopic dermatitis;Bizikova P;Vet Dermatol,2015
4. A blinded, randomized, placebo-controlled, dose determination trial of lokivetmab (ZTS-00103289), a caninized, anti-canine IL-31 monoclonal antibody in client owned dogs with atopic dermatitis;Michels GM;Vet Dermatol,2016
5. A prospective study on the clinical features of chronic canine atopic dermatitis and its diagnosis;Favrot C;Vet Dermatol,2010